Artesunate plus mefloquine versus mefloquine for treating uncomplicated malaria
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Artesunate Plus Mefloquine Versus Mefloquine for Treating Uncomplicated Malaria." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/439085/all/Artesunate_plus_mefloquine_versus_mefloquine_for_treating_uncomplicated_malaria.
Artesunate plus mefloquine versus mefloquine for treating uncomplicated malaria. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439085/all/Artesunate_plus_mefloquine_versus_mefloquine_for_treating_uncomplicated_malaria. Accessed March 19, 2025.
Artesunate plus mefloquine versus mefloquine for treating uncomplicated malaria. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439085/all/Artesunate_plus_mefloquine_versus_mefloquine_for_treating_uncomplicated_malaria
Artesunate Plus Mefloquine Versus Mefloquine for Treating Uncomplicated Malaria [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 March 19]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/439085/all/Artesunate_plus_mefloquine_versus_mefloquine_for_treating_uncomplicated_malaria.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Artesunate plus mefloquine versus mefloquine for treating uncomplicated malaria
ID - 439085
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/439085/all/Artesunate_plus_mefloquine_versus_mefloquine_for_treating_uncomplicated_malaria
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -